The 5 Most Interesting Analyst Questions From IMAX’s Q2 Earnings Call

IMAX Cover Image

IMAX’s second quarter results modestly surpassed Wall Street’s expectations, as management credited growth in system installations and significant box office gains for the company’s operating performance. CEO Richard Gelfond cited a 50% increase in installations and over 40% box office growth as key factors. The company’s strategy to focus on “film for IMAX” releases, which feature exclusive content and marketing partnerships with studios, helped drive higher per-screen averages and market share. Gelfond noted, “We’re moving higher in our range for full year installations to between 150 and 160 systems worldwide.”

Is now the time to buy IMAX? Find out in our full research report (it’s free).

IMAX (IMAX) Q2 CY2025 Highlights:

  • Revenue: $91.68 million vs analyst estimates of $90.79 million (3.1% year-on-year growth, 1% beat)
  • Adjusted EPS: $0.26 vs analyst estimates of $0.23 (15.1% beat)
  • Adjusted EBITDA: $36.69 million vs analyst estimates of $33.4 million (40% margin, 9.8% beat)
  • Operating Margin: 15.6%, up from 3.2% in the same quarter last year
  • Market Capitalization: $1.38 billion

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions IMAX’s Q2 Earnings Call

  • Omar Mejias Santiago (Wells Fargo) asked whether IMAX’s film-for-IMAX strategy could eventually encompass most releases. CEO Richard Gelfond replied that while the approach will expand, not all films are suitable, and exclusivity remains important.

  • Chad Beynon (Macquarie) questioned if IMAX’s recent performance strengthens its negotiating position with content providers. Gelfond indicated that while leverage has increased, the company prefers to use it for better marketing and partnerships rather than differing pricing models.

  • Eric Handler (ROTH Capital) inquired about the role and future of local language and alternative content. Gelfond highlighted local language films’ growing box office contribution and said alternative content is valuable but not likely to match Hollywood titles in impact.

  • Eric Wold (Texas Capital Securities) asked about the possible effects of widespread midweek ticket discounting on IMAX’s business. Gelfond responded that IMAX’s customers remain willing to pay a premium and that discounting by exhibitors is unlikely to change this dynamic.

  • Stephen Laszczyk (Goldman Sachs) requested an update on cash flow conversion trends. CFO Natasha Fernandes stated that operating cash flow is improving and trending toward pre-pandemic levels, with higher box office directly benefiting cash generation.

Catalysts in Upcoming Quarters

In the coming quarters, the StockStory team will monitor (1) the rollout and box office performance of upcoming “film for IMAX” titles, (2) the pace of new system installations and signings in key international markets, and (3) progress in diversifying content offerings, particularly local language films and alternative events. Continued operational discipline and execution on backlog conversion will be additional markers we track.

IMAX currently trades at $25.66, down from $29.04 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it’s free).

Our Favorite Stocks Right Now

When Trump unveiled his aggressive tariff plan in April 2024, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.

Don’t let fear keep you from great opportunities and take a look at Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.